← All indications
Urethral Neoplasms
Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.
Drugs by status
Phase 3 trials (14)
Phase 2 trials (41)
- afatinib
- rucaparib
- alt-801
- atezolizumab
- azd-4877
- sorafenib
- irinotecan
- temsirolimus
- fluorouracil
- il-7
- ramucirumab
- icrucumab
- nivolumab
- mitomycin
- ixabepilone
- pembrolizumab
- leucovorin
- pazopanib
- pemetrexed
- piritrexim
- trastuzumab
- ifosfamide
- propranolol
- ipilimumab
- sunitinib
- rubitecan
- sch66336
- arsenic trioxide
- tocilizumab
- bortezomib
- +11 more
Organizations
Organization Involved with Phase 3 Indications (24)
- Central European Cooperative Oncology Group
- Medical Research Council
- National Cancer Institute (NCI)
- Canadian Cancer Trials Group
- Cancer and Leukemia Group B (CALGB)
- University of London
- Eastern Cooperative Oncology Group
- Seoul National University
- Southwest Oncology Group
- Spanish Oncology Genito-Urinary Group
- University of Michigan
- University of Toronto
- Groupe D'Etude des Tumeurs Uro-Genitales
- University of Ulsan
- Vanderbilt University
- Medical University of Vienna
- University of Montpellier
- European Organisation for Research and Treatment of Cancer
- Universidad Autonoma de Barcelona
- University of Western Australia
- Department of Veteran Affairs
- Universitaetsklinikum Schleswig-Holstein
- Klinikum Nuernberg - Klinikum Nord
- German Association of Urologic Oncology
Organization Involved with Phase 2 Indications (34)
- Seattle Genetics
- Astellas
- AstraZeneca
- Genentech
- Pfizer
- OncoGenex Technologies
- University of Pennsylvania
- Centre Georges Francois Leclerc
- Cornell University
- Temple University
- Herbert Irving Comprehensive Cancer Center
- Oregon Health and Science University
- Radboud University
- The Royal Bournemouth Hospital
- University of Florida
- University of Glasgow
- UNICANCER
- University of Leeds
- University of Milan
- University of Rochester
- University of Southern California
- Wayne State University
- Mayo Clinic
- Cardiff University
- University of California, Davis
- University of Chicago
- Leiden University
- Cancer Immunotherapy Trials Network
- Karolinska Institute
- City of Hope National Medical Center
- +4 more
Organization Involved with Phase 1 Indications (13)